Sökning: "atrial fibrillation burden"
Visar resultat 11 - 15 av 24 avhandlingar innehållade orden atrial fibrillation burden.
11. Diabetes complications, risk factors, and glycaemic indices in persons with type 1 diabetes
Sammanfattning : Background: Persons with type 1 diabetes are at higher risk of cardiovascular disease and mortality. An important risk factor for diabetes complications is hyperglycaemia. Hyperglycaemia has traditionally been measured using HbA1c, but glycaemic targets are also provided for continuous glucose monitoring. LÄS MER
12. Exposure-based cognitive behavior therapy for atrial fibrillation : a novel treatment paradigm
Sammanfattning : Background: Atrial fibrillation (AF) is a prevalent arrhythmia associated with symptoms such as irregular heartbeat, palpitations, dyspnea, chest pain and fatigue. In many patients, AF symptoms are not alleviated by current treatment strategies and there is a clinical need for better symptom management. LÄS MER
13. Structured management, Symptoms, Health-related Quality of Life and Alcohol in Patients with Atrial Fibrillation
Sammanfattning : Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting at least 2.9 % of the Swedish population. Although AF is associated with increased risk of ischaemic stroke, there have been many reports on the underuse of oral anticoagulants (OAC) and non-adherence to guidelines in other areas as well. LÄS MER
14. Diabetes and glucose abnormalities in cardiovascular disease : studies on prevalence and prognosis in myocardial infarction and atrial fibrillation
Sammanfattning : Background: Cardiovascular disease and diabetes are both common chronic conditions associated with a high disease and economic burden globally. Diabetes increases the risk of cardiovascular disease and leads to a worse prognosis after a cardiovascular event. LÄS MER
15. Immune cells in chronic lymphocytic leukemia and Hodgkin lymphoma in relation to tumor burden and treatment
Sammanfattning : B-cell malignancies are a heterogeneous group of cancers that originate from lymphoidlineage cells that are responsible for humoral immunity. When B-cell development goes wrong, chronic lymphocytic leukemia (CLL) and classical Hodgkin lymphoma (cHL), among other malignancies, may arise. Recent advances in the treatment of these diseases, e.g. LÄS MER